Management of Active Duodenal Ulcer Bleeding
Active duodenal ulcer bleeding requires urgent endoscopic hemostasis combined with high-dose proton pump inhibitor (PPI) therapy—specifically an 80 mg IV bolus followed by continuous infusion at 8 mg/hour for 72 hours after successful endoscopic treatment.
Initial Resuscitation and Risk Assessment
Before endoscopy, patients must be hemodynamically stabilized with appropriate fluid resuscitation and blood transfusion (target hemoglobin ≥7 g/dL). Endoscopy should only be performed once resuscitation is adequate, though complete hemodynamic stability may not always be achievable in actively bleeding patients 1.
Consider administering erythromycin infusion (250 mg IV) 30-60 minutes before endoscopy to improve gastric emptying and visualization 2, 3.
Urgent Endoscopic Therapy
Endoscopy should be performed within 24 hours of presentation 3. For actively bleeding duodenal ulcers with high-risk stigmata (spurting arterial bleeding, oozing, or visible vessel), endoscopic hemostasis is mandatory and reduces rebleeding, need for surgery, and mortality 1.
Recommended Endoscopic Techniques:
Combination therapy is superior to monotherapy for active arterial bleeding 1. The evidence supports:
- Epinephrine injection (1:10,000 dilution, 4-16 mL total) PLUS thermal coagulation (heater probe at 20-30 joules or bipolar electrocoagulation) 1, 4
- Epinephrine injection PLUS mechanical clips for large visible vessels 1, 4
Critical caveat: Epinephrine injection alone is inadequate and should never be used as monotherapy—it must be combined with another modality 4. Adding sclerosants to epinephrine provides no additional benefit and risks tissue necrosis 1.
For patients where conventional therapy fails, hemostatic powder (TC-325) can serve as temporizing therapy, though it should not replace standard endoscopic methods 4.
Pharmacologic Management
High-Dose PPI Therapy
After successful endoscopic hemostasis, administer high-dose IV PPI therapy: 80 mg omeprazole (or equivalent) bolus followed by 8 mg/hour continuous infusion for 72 hours 1, 4. This regimen significantly reduces rebleeding rates, blood transfusion requirements, and hospital stay 1.
Following the 72-hour infusion, transition to twice-daily oral PPI for 14 days, then once-daily 4. Continue single daily-dose PPI for 6-8 weeks to allow complete mucosal healing 2.
Important note: PPI therapy does not replace urgent endoscopy—it is adjunctive treatment 5.
H. pylori Testing and Eradication
All patients must be tested for H. pylori and receive eradication therapy if positive 5. This is critical because H. pylori eradication dramatically reduces ulcer recurrence and rebleeding rates 5.
Key pitfall: Acute bleeding increases false-negative rates for H. pylori testing 5. If initial testing is negative, repeat testing after the acute bleeding episode 4. Oral eradication therapy can begin immediately or during follow-up—there is no need for urgent IV therapy 5.
Management of Rebleeding
If rebleeding occurs (fresh hematemesis, melena, hemodynamic instability):
- Repeat endoscopy is the first-line approach 2, 4
- If second endoscopic attempt fails, transcatheter arterial embolization (TAE) is recommended over surgery 2, 3, 6
TAE has emerged as the preferred salvage therapy, particularly in elderly patients or those with significant comorbidities, with technical success rates of 98% and lower morbidity than surgery 7, 8. Surgery should be reserved for patients in whom both endoscopy and TAE have failed 2, 4.
Prophylactic TAE in High-Risk Patients
For duodenal ulcers ≥2 cm, posterior bulbar location, elderly patients with shock on presentation, or those with comorbidities, prophylactic TAE of the gastroduodenal artery after successful endoscopic hemostasis may be considered 6, 9, 7. This approach reduces rebleeding to 11% and nearly eliminates the need for emergency surgery 7, though this remains an evolving strategy requiring further validation.
Post-Endoscopy Management
- Low-risk patients (clean-based ulcer, flat spot) can be fed within 24 hours and may be discharged after stabilization 5
- High-risk patients (those requiring endoscopic therapy) should be hospitalized for at least 72 hours with close monitoring of vital signs and hemoglobin 4
- Routine second-look endoscopy is not recommended 4
NSAID-Related Ulcers
If the ulcer is NSAID-related, discontinue NSAIDs immediately. If NSAIDs cannot be stopped, continue PPI therapy indefinitely 5. The same endoscopic and pharmacologic management principles apply 5.